Jessica Hagen
Execs overwhelmingly cite genAI as having the most significant impact in healthcare this year, though others provide alternative takes on the years' events.
The partners will initially launch in two clinics in Texas to provide patients with ALS access to virtual-first specialty care providers, including respiratory therapists.
Dr. Michael Howell, chief clinical officer at Google, discusses Med-PaLM's evolution in 2023 and recommendations for regulators developing rules for AI use in healthcare.
The company's CEO said it is leaving the CMS program at the end of the performance year due to not seeing a clear path to profitability.
The gastrointestinal surgery-focused company will use the funds to advance its endoluminal robotics technology for minimally invasive procedures.
Rx Savings Finder allows Walgreens' pharmacy customers to access low-cost prescriptions by comparing the price of medications on third-party discount cards.
The company scored Class III Shonin clearance in Japan for its stroke platform and launched Rapid Edge Cloud, allowing continued AI access despite cloud connectivity.
The partnership will give St. Luke's Health System employees access to TytoCare's Home Smart Clinic and its plan members access to virtual visits with a $0 copay.
The funds will be used to develop a comprehensive AI imaging model powered by imaging data to improve diagnostic precisions and early detection of conditions.
The low-cost drug service will be part of Florida-based PharmcoRx's in-pharmacy offerings and will integrate into Expion Health's product suite.